Clinical trial

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic…

NCT00437060 · Children's Oncology Group, Other · Completed

Key facts

NCT number NCT00437060
Title Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Official title A Study of Neurocognitive Function in Children Treated for ALL
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Observational
Conditions Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia, Cognitive Side Effects of Cancer Therapy, Long-Term Effects Secondary to Cancer Therapy in Children, Neurotoxicity Syndrome, Psychological Impact of Cancer, Untreated Childhood Acute Lymphoblastic Leukemia
Intervention type Other, Procedure
Interventions Cognitive Assessment, Diffusion Tensor Imaging, Laboratory Biomarker Analysis, Pharmacological Study, Psychosocial Assessment and Care
Enrollment 233
Start date Jan 1, 2007
Primary completion Sep 1, 2015
First posted Feb 19, 2007
Last update posted Jul 21, 2017
Countries Australia, Canada, New Zealand, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies